LCL768
Product Specifications
Target
Mitochondrial Metabolism, Mitophagy, PTEN
Related Pathways
Autophagy, Metabolism, PI3K/Akt/mTOR signaling
Bioactivity
LCL768 is a ceramide analogue that attenuates PARKIN succinylation, thereby promoting PARKIN activation and mitophagy. It induces the accumulation of CerS1-mediated endogenous C18-ceramide in mitochondria, facilitating mitophagy through DRP1 activation via C644 site nitrosylation. Additionally, LCL768 alters mitochondrial metabolism, depleting fumarate and inhibiting tumor growth. Furthermore, it ameliorates sensorimotor deficits in neurodegenerative diseases such as ALS.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4035106 1.0 µg DNA
2310002L09Rik sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details sc-224105 10 mg
N-[ (1R,2R) -1,2,3,4-Tetrahydro-1-hydroxy-7-methoxy-2-naphthalenyl]-chloroacetamide
Sign In for Pricing
View Details MBS1453155 Inquire
Recombinant Human Serine/threonine-protein kinase Nek9 (NEK9) , partial
Sign In for Pricing
View Details